Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.
Institute of Genetics, Department of Biology, University of Erlangen-Nürnberg, Staudtstr. 5, 91058 Erlangen, Germany.
Inessa
I
Schwab
Institute of Genetics, Department of Biology, University of Erlangen-Nürnberg, Staudtstr. 5, 91058 Erlangen, Germany.
Anja
A
Lux
Institute of Genetics, Department of Biology, University of Erlangen-Nürnberg, Staudtstr. 5, 91058 Erlangen, Germany.
Falk
F
Nimmerjahn
D000818:Animals; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D056747:Immunomodulation / Q000187:drug effects*; D007165:Immunosuppression Therapy
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous